G-CSF after chemotherapy for acute myeloid leukemia (AML) - Interim analysis of a placebo controlled trial

被引:0
|
作者
Link, H
Wandt, H
SchonrockNabulsi, P
Ehninger, G
Franke, A
Gackle, R
Geer, T
Gramatzki, M
Linkesch, W
Lutz, D
Niederwieser, D
Nikiforakis, E
Ohl, S
Otremba, B
Pittermann, E
Schmidt, H
Tischler, J
Weiss, J
Wilhelm, M
Deutschmann, S
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:841 / 841
页数:1
相关论文
共 50 条
  • [21] Complete remission in hypoplastic acute myeloid leukemia induced by G-CSF without chemotherapy: report on three cases
    S Nimubona
    I Grulois
    M Bernard
    B Drénou
    M Godard
    R Fauchet
    T Lamy
    Leukemia, 2002, 16 : 1871 - 1873
  • [22] Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia
    Minakata, Daisuke
    Fujiwara, Shin-ichiro
    Ikeda, Takashi
    Toda, Yumiko
    Ito, Shoko
    Mashima, Kiyomi
    Umino, Kento
    Nakano, Hirofumi
    Yamasaki, Ryoko
    Morita, Kaoru
    Kawasaki, Yasufumi
    Sugimoto, Miyuki
    Yamamoto, Chihiro
    Ashizawa, Masahiro
    Hatano, Kaoru
    Sato, Kazuya
    Oh, Iekuni
    Ohmine, Ken
    Muroi, Kazuo
    Kanda, Yoshinobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (03) : 411 - 417
  • [23] Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia
    Daisuke Minakata
    Shin-ichiro Fujiwara
    Takashi Ikeda
    Yumiko Toda
    Shoko Ito
    Kiyomi Mashima
    Kento Umino
    Hirofumi Nakano
    Ryoko Yamasaki
    Kaoru Morita
    Yasufumi Kawasaki
    Miyuki Sugimoto
    Chihiro Yamamoto
    Masahiro Ashizawa
    Kaoru Hatano
    Kazuya Sato
    Iekuni Oh
    Ken Ohmine
    Kazuo Muroi
    Yoshinobu Kanda
    International Journal of Hematology, 2017, 106 : 411 - 417
  • [24] Economic evaluation of G-CSF use in the therapy of adult acute myelogenous leukemia (AML).
    Maslak, P
    Weiss, M
    Berman, E
    Tyson, D
    Sheinberg, D
    BLOOD, 1996, 88 (10) : 827 - 827
  • [25] GM-CSF IN A DOUBLE-BLIND RANDOMIZED, PLACEBO CONTROLLED TRIAL IN THERAPY OF ADULT PATIENTS WITH DENOVO ACUTE MYELOID-LEUKEMIA (AML)
    HEIL, G
    CHADID, L
    SEIPELT, G
    MITROU, P
    HOELZER, D
    KOLBE, K
    HUBER, C
    LINDEMANN, A
    MERTELSMANN, R
    FRISCH, J
    NICOLAY, U
    GAUS, W
    HEIMPEL, H
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 786 - 786
  • [26] Mobilisation of haemopoetic stem cells with G-CSF after unsuccess with chemotherapy and G-CSF
    Mihaylov, G
    Avramova, B
    Jordanova, M
    Gartcheva, L
    Bobev, D
    BONE MARROW TRANSPLANTATION, 2005, 35 : S367 - S367
  • [27] G-CSF priming in acute myelogenous leukemia
    Murashige, N
    Kami, M
    Takaue, Y
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21): : 2071 - 2072
  • [28] Increased numbers of bone marrow blasts in acute myeloid leukaemia patients treated with G-CSF after chemotherapy
    Kaddar, A
    Edinger, M
    Wirth, K
    Schaefer, HE
    Lubbert, M
    Lindemann, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (02) : 492 - 493
  • [29] FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia
    Huhmann, IM
    Watzke, HH
    Geissler, K
    Gisslinger, H
    Jager, U
    Knobl, P
    Pabinger, I
    Korninger, L
    Mannhalter, C
    Mitterbauer, G
    Schwarzinger, I
    Kalhs, P
    Haas, OA
    Lechner, K
    ANNALS OF HEMATOLOGY, 1996, 73 (06) : 265 - 271
  • [30] Myelodysplasia and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy
    Freedman, MH
    Bonilla, MA
    Fier, C
    Bolyard, AA
    Scarlata, D
    Boxer, LA
    Brown, S
    Cham, B
    Kannourakis, G
    Kinsey, SE
    Mori, PG
    Cottle, T
    Welte, K
    Dale, DC
    LEUKEMIA, 2000, 14 (05) : 964 - 964